DNA X Inc
SONM
12 hedge funds and large institutions have $346K invested in DNA X Inc in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more ownership
Funds ownership: 0.01% → 0.02% (+0%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
8% less funds holding
Funds holding: 13 → 12 (-1)
20% less capital invested
Capital invested by funds: $435K → $346K (-$88.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$63.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$46.6K |
| 3 |
VF
Virtu Financial
New York
|
+$27.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.9K |
| 5 |
SG
StoneX Group
New York
|
+$7.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
E
Ergoteles
New York
|
-$21K |
| 2 |
Renaissance Technologies
New York
|
-$21K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$17K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.63K |
| 5 |
Citigroup
New York
|
-$2.71K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Bank of New York Mellon
New York
| $120K | -$903 | -8 | -0.7% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $68K | +$46.6K | +413 | +149% |
|
|
3
Millennium Management
New York
| $56K | +$63.7K | +564 | New |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $41K | +$7.9K | +70 | +20% |
|
|
VF
5
Virtu Financial
New York
| $24K | +$27.8K | +246 | New |
|
|
6
Citigroup
New York
| $19K | -$2.71K | -24 | -11% |
|
|
SG
7
StoneX Group
New York
| $6.34K | +$7.23K | +64 | New |
|
8
Morgan Stanley
New York
| $6K | +$5.76K | +51 | +638% |
|
|
WAP
9
Wealthcare Advisory Partners
West Chester,
Pennsylvania
| $6K | +$6.44K | +57 | New |
|
|
E
10
Ergoteles
New York
| – | -$21K | -139 | Closed |
|
|
11
Renaissance Technologies
New York
| – | -$21K | -134 | Closed |
|
|
TSS
12
Two Sigma Securities
New York
| – | -$17K | -113 | Closed |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| – | -$4.63K | -41 | Closed |
|
14
Fidelity Investments
Boston,
Massachusetts
| – | +$113 | +1 | +100% |
|
SONM Hedge Fund Activity: Q2 2022 in Review
12 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q2 2022, worth a combined $346K — down 20% from $435K a quarter earlier.
Fund positioning in SONM was balanced in Q2 2022: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $63.7K. The largest seller was Ergoteles, exiting entirely with an estimated $21K sold.
- 12 institutional investors held DNA X Inc (SONM) as of Q2 2022, down from 13 in Q1 2022.
- Funds reported $346K of DNA X Inc stock for Q2 2022, down 20% quarter-over-quarter.
- 4 funds opened new DNA X Inc positions in Q2 2022 and 4 closed out, a net change of 0 holders.
- The largest DNA X Inc buyer in Q2 2022 was Millennium Management, an estimated $63.7K added.
- The largest DNA X Inc seller in Q2 2022 was Ergoteles, an estimated $21K sold.
Based on aggregated 13F filings for Q2 2022.